Final answer:
The likelihood of seroconversion following a needlestick injury varies by pathogen but can be high for certain diseases such as hepatitis B. Exact probabilities cannot be provided without knowing the specific pathogen. Preventative measures and post-exposure protocols are crucial to minimize the risk.
Step-by-step explanation:
The likelihood of seroconversion after a needlestick from a known carrier of disease varies depending on the pathogen involved. Without specifying the disease in question, it's impossible to provide an exact likelihood. However, for illustrative purposes, let's consider the hepatitis B virus (HBV), as healthcare workers are a group at risk for this exposure. The risk of seroconversion after a needlestick exposure to HBV from a known carrier has been reported to be as high as 30% without post-exposure prophylaxis. In the case of HIV, the risk is estimated to be about 0.3%. It's important to follow post-exposure protocols like hepatitis B immunoglobulin (HBIG) and vaccination for HBV, or antiretroviral therapy for HIV, to reduce the risk of seroconversion.
As for calculating percentages, like the percentage of seropositive students, add the positive and negative cases together to find the total number of tested students, and then divide the number of positive cases by the total number to find the percentage. For instance, if 9 students tested positive for Toxoplasma antibodies and 28 tested negative, the total tested would be 37 (9+28), and the percentage of seropositive students would be (9/37) * 100%, which is approximately 24.32%.